Category: Radiopharmaceuticals
Global Radiopharmaceuticals
-
Global Radiopharmaceutical Injector Industry Research Report, Growth Trends and Competitive Analysis 2023-2029
... a CAGR of 7.35% during the forecast period (2023-2029). The global key manufacturers of Radiopharmaceutical Injector include Medrad, Inc.(Bayer), UNIVERSAL GIKEN, Comecer, Sumitomo Heavy Industries, Tema Sinergie, Lemer Pax, BQSV, and etc. In 2022, the ... Read More
-
Global Theranostics Market - 2023-2030
... is to exhibit a CAGR of 11.3% during the forecast period (2023-2030). Theranostics is a combination of the terms therapeutics and diagnostics. Theranostics is the term used to describe the combination of using one radioactive ... Read More
-
Global Radiopharmaceutical Theranostics Market Report and Forecast 2023-2031
... the need for effective and precise treatment options across the globe. The market size is anticipated to grow at a CAGR of 13.8% during the forecast period of 2023-2031 to achieve a value of USD ... Read More
-
Global Oncology Radiopharmaceutical Supply, Demand and Key Producers, 2023-2029
... (2023-2029). This report studies the global Oncology Radiopharmaceutical production, demand, key manufacturers, and key regions. This report is a detailed and comprehensive analysis of the world market for Oncology Radiopharmaceutical, and provides market size (US$ ... Read More
-
Global Oncology Radiopharmaceutical Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
... and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. This ... Read More
-
Global Oncology Radiopharmaceutical Market Growth 2023-2029
... % from 2023 to 2029. United States market for Oncology Radiopharmaceutical is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. China ... Read More
-
Global Radiotheranostics Market Size study & Forecast, by Radioisotope (Iodine-131, Iodine-123, Gallium-68, Lutetium-177, 18F with Y-90, Others), by Approach (Targeted Therapeutic, Targeted Diagnostic), by Application (Oncology, Non Oncology) by and Regional Analysis, 2023-2030
... Market is valued at approximately USD 7.51 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 13.49% over the forecast period 2023-2030. Radiotheranostics refers to the field of ... Read More
-
Global Radiopharmaceuticals Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029
... Radiopharmaceuticals are unique medicinal formulations containing radioisotopes that are used in major clinical areas, and monitored via specific imaging devices, for diagnosis and/or therapy. Market Overview: The latest research study on the global Radiopharmaceuticals market ... Read More
-
Global Radiopharmaceuticals Market - Industry Trends and Forecast to 2030
... during the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030. Market ... Read More
-
Global Diagnostic Radiopharmaceuticals Market Research Report 2023(Status and Outlook)
... medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases. North ... Read More
-
Global Radiopharmaceuticals Market Report and Forecast 2023-2031
... value is anticipated to grow at a CAGR of 7.50% during the forecast period of 2023-2031 to achieve a value of USD 9.53 billion by 2031. Radiopharmaceuticals: Introduction Radiopharmaceuticals, also known as radioactive drugs or ... Read More
-
Global Lutetium-177 Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029
... Lu-177 with numerous biologically active compounds. Market Overview: The latest research study on the global Lutetium-177 market finds that the global Lutetium-177 market reached a value of USD 65.25 million in 2022. It’s expected that ... Read More
-
Nuclear Medicine Market / Radiopharmaceuticals Market by Type (Diagnostic (SPECT-Technetium, PET-F-18), Therapeutic (Beta Emitters-Y-90, Alpha Emitters, Brachytherapy), Application (Neurology,Thyroid, Oncology), Procedures, End User - Global Forecast to 2028
... to reach USD 9.4 billion by 2028 from USD 5.5 billion in 2023, at a CAGR of 11.3% during the forecast period. Growth in the nuclear medicine market can primarily be attributed to factors such ... Read More
-
Radiopharmaceuticals Market By Radioisotope (Technetium 99m, Fluorine 18, Iodine I, Gallium 68, Others), By Application (Cancer, Cardiology, Others), By Type (Diagnostic, Therapeutic), By End User (Hospitals and clinics, Medical Imaging centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
... and Industry Forecast, 2023-2032 The radiopharmaceuticals market was valued at $5.2 billion in 2022, and is estimated to reach $13.7 billion by 2032, growing at a CAGR of 10.2% from 2023 to 2032. Radiopharmaceutical is ... Read More
-
Radiopharmaceutical Theranostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type [Alpha Emitters, Beta Emitters, and Positron Emission Tomography (PET) Tracers], Radioisotope [Technetium-99, Gallium-68, Iodine-131, Iodine-123, 18F, Y-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (DX)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic and Research Institutes, and Others)
... Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (DX)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic ... Read More
-
Global Radiopharmaceuticals Market 2023-2029
... the therapy of diseases. Radiopharmaceuticals may be given to the patient in several different ways. For example, they may be given by mouth, given by injection, or placed into the eye or into the bladder. ... Read More
-
Diagnostic Radiopharmaceuticals and Contrast Media Market Size Outlook in 2023 and Beyond: Market Trends, Insights, Growth Opportunities, Market Share and Forecasts by Types, Applications, Countries and Companies to 2030
... Media industry is expected to register solid growth in the sector in 2023 and beyond. The Diagnostic Radiopharmaceuticals and Contrast Media market report analyzes the Diagnostic Radiopharmaceuticals and Contrast Media market growth opportunities, trends, insights, ... Read More
-
Radiopharmaceuticals Market Intelligence Report - Global Forecast 2023-2030
... Market Statistics: The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, ... Read More
-
Global Diagnostic Radiopharmaceuticals Market Growth 2023-2029
... the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases. LPI (LP Information)' newest research report, ... Read More
-
Global Radiopharmaceuticals Market Growth 2023-2029
... The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and ... Read More
-
Global Nuclear Medicine & Radiopharmaceuticals Market Growth 2023-2029
... properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the ... Read More
-
Global Radiopharmaceutical Market Growth 2023-2029
... The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and ... Read More
-
Global Radiopharmaceuticals Market - 2022-2029
... 2022 to 2029. Radiopharmaceuticals contain radioactive substances used to diagnose or treat diseases, including cancer or cardiology. These are used for the diagnosis of abscess and infection, blood vessel diseases, bone diseases, colorectal disease and ... Read More
-
Global Radiotheranostics Market By Radioisotope (Technetium-99, Gallium-68, Iodine-131, Iodine-123, 18F, Y-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, Others), By Application (Oncology v/s Non-Oncology), By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others) and By Region, Competition Forecast and Opportunities, 2027
... Companies, Others) and By Region, Competition Forecast and Opportunities, 2027 Global radiotheranostics market is anticipated to register growth at an impressive CAGR in the forecast period, 2023-2027. Radiotheranostics is a process that involves the use ... Read More
-
Global SPECT Radiopharmaceuticals Market Research Report 2021-2032
... provide a comprehensive outlook of the global market. Additionally, the report also highlights the challenges impeding market growth and expansion strategies employed by leading companies in the “SPECT Radiopharmaceuticals Market”. Key Companies Profiled in the ... Read More
Research Assistance
